Opus Genetics, Inc. (IRD) intrinsic value & 10-year financials
Opus Genetics, Inc. (IRD) has a Graham intrinsic value of $28.90 per share. At $3.84 on Oct 17, 2026, the stock trades 87% below that value. Over the last 10 fiscal years revenue grew 29.6% a year to $14.2M, with an average return on invested capital of 196.3%.
- Graham intrinsic value
- $28.90
- Share price (Oct 17, 2026)
- $3.84
- Price vs Graham value
- 87% below
- Market cap
- $238.9M
- Revenue (FY2025)
- $14.2M
- Revenue growth (10-yr CAGR)
- 29.6%
- ROIC (10-yr avg)
- 196.3%
- Free cash flow (FY2025)
- —
IRD 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $14.2M | -$49.6M | -$0.80 | — | -271.9% | 147.9% |
| FY2024 | $11.0M | -$57.5M | -$2.15 | — | -564.7% | 263.1% |
| FY2023 | $19.0M | -$10.0M | -$0.46 | — | -55.5% | -293.0% |
| FY2022 | $39.9M | $17.9M | $0.87 | — | 45.7% | 1956.4% |
| FY2021 | $589.0K | -$56.7M | -$3.82 | — | -3854.8% | 143.5% |
| FY2020 | $0 | -$24.6M | -$5.28 | — | — | 186.8% |
| FY2019 | $3.0M | -$8.6M | — | -$10.3M | -373.8% | -132.2% |
| FY2018 | — | -$14.4M | — | — | — | -105.1% |
| FY2017 | — | -$25.3M | — | — | — | -149.6% |
| FY2016 | — | -$9.3M | — | — | — | -54.6% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Opus Genetics, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Opus Genetics, Inc. has earned high returns on invested capital, averaging 25.8% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Opus Genetics, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Opus Genetics, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $28.90 per share.